Technical Analysis for IKT - Inhibikase Therapeutics, Inc.

Grade Last Price % Change Price Change
F 6.84 -2.70% -0.19
IKT closed down 2.7 percent on Friday, January 15, 2021, on 28 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical IKT trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Hot IPO Pullback Bullish Swing Setup -2.70%
Hot IPO Pullback Bullish Swing Setup -8.43%
Narrow Range Bar Range Contraction -8.43%
Hot IPO Pullback Bullish Swing Setup -8.43%
NR7 Range Contraction -8.43%
Inside Day Range Contraction -8.43%
Bearish Engulfing Bearish -6.30%
Older End-of-Day Signals for IKT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inhibikase Therapeutics, Inc. Description

Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease, and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a c-Abl protein kinase inhibitor for use in the treatment of Parkinson's Disease, dysphagia, and neurogenic constipation; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects. Its research phase products comprise IkT-01427, a product candidate that blocks the causative virus of progressive multifocal leukoencephalopathy from replicating in the body; and IkT-148x series of portfolio compounds for use in the treatment of Dementia with Lewy Body and Multiple System Atrophy. The company was founded in 2008 and is headquartered in Atlanta, Georgia.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords:

Is IKT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.8
52 Week Low 6.42
Average Volume 370,501
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 7.22
Average True Range 0.98
ADX 0.0
+DI 6.87
-DI 23.94
Chandelier Exit (Long, 3 ATRs ) 8.87
Chandelier Exit (Short, 3 ATRs ) 9.35
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -0.20
MACD Signal Line -0.08
MACD Histogram -0.1173
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.54
Resistance 3 (R3) 7.54 7.31 7.42
Resistance 2 (R2) 7.31 7.14 7.31 7.38
Resistance 1 (R1) 7.08 7.03 6.96 7.07 7.34
Pivot Point 6.85 6.85 6.79 6.85 6.85
Support 1 (S1) 6.61 6.67 6.50 6.61 6.34
Support 2 (S2) 6.38 6.56 6.38 6.30
Support 3 (S3) 6.15 6.38 6.26
Support 4 (S4) 6.14